Angion Biomedica (ANGN) Competitor Comparison
We are evaluating the key criteria listed to compare Angion Biomedica (ANGN) against its competitors in the Biotechnology industry.
Market Capitalization
314 / 368Gross Profits
166 / 278Total Revenue
248 / 300EBITDA
86 / 337Free Cashflow
158 / 352Quick Ratio
45 / 357Earnings per Share
337 / 359Dividend yield
0 / 6Total Cash
285 / 358Performance 3 years
326 / 368Performance 5 years
306 / 368Performance 10 years
274 / 368Linearity 3 years
267 / 368Linearity 5 years
273 / 368Linearity 10 years
240 / 368Total Rank
290 / 368Dividend Rank
350 / 368Valuation Rank
341 / 368Piotroski Rank
257 / 368Muliplier Rank
269 / 368Total Cash - ANGN ranking 285 / 358
Obligatory risk notice
We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.